Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
6,619,817
-
Share change
-
-1,866,944
-
Total reported value
-
$383,723,138
-
Price per share
-
$58.40
-
Number of holders
-
34
-
Value change
-
-$108,937,499
-
Number of buys
-
21
-
Number of sells
-
11
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q1 2020
As of 31 Mar 2020,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,619,817 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Artal Group S.A., FMR LLC, PLATINUM INVESTMENT MANAGEMENT LTD, Redmile Group, LLC, DekaBank Deutsche Girozentrale, SCHRODER INVESTMENT MANAGEMENT GROUP, Vident Investment Advisory, LLC, Avitas Wealth Management LLC, and DEUTSCHE BANK AG\.
This page lists
34
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.